Safety and immunogenicity of a single dose, live-attenuated ‘tetravalent dengue vaccine’ in healthy Indian adults; a randomized, double-blind, placebo controlled phase I/II trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of a single dose, live-attenuated ‘tetravalent dengue vaccine’ in healthy Indian adults; a randomized, double-blind, placebo controlled phase I/II trial

Published:2022-04 Issue: Volume:10 Page:100142
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Mohanty Lalitendu,Prabhu Madhav,Kumar Mishra Amit,Purty Anil J,Kanungo Reba,Ghosh Goutam^ORCID,Prahan Kumar R,Newton Raj A.,Bhushan Sumit,Kumar Jangir Manoj,Gupta Anu,Bhakri Anju

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. Dengue;Wilder-Smith;Lancet,2019

2. World Health Organization (WHO). Dengue and severe Dengue, Fact sheets. Available online: https://www.who.int/news-room/fact-sheets/detail/Dengue-and-severe-Dengue (cited: 2020, June 23rd)

3. Secondary infection as a risk factor for Dengue hemorrhagic fever/Dengue shock syndrome: an historical perspective and role of antibody- dependent enhancement of infection;Guzman;Arch Viral,2013

4. Global spread of Dengue virus types: mapping the 70 year history;Messina;Trends Microbiol,2014

5. Country Office for India, World Health Organization (WHO) 2015. National Guidelines for Clinical Management of Dengue Fever. National Vector Borne Disease Control Programme. Available online: https://apps.who.int/iris/handle/10665/208893

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An effective pan-serotype dengue vaccine and enhanced control strategies could help in reducing the severe dengue burden in Bangladesh–A perspective;Frontiers in Microbiology;2024-08-20

2. The Urgent Need for Dengue Vaccination: Combating an Escalating Public Health Crisis in Pakistan;Vaccines;2024-08-13

3. Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates;Viruses;2024-05-05

4. Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial;The Lancet Infectious Diseases;2024-02

5. Facing the escalating burden of dengue: Challenges and perspectives;PLOS Global Public Health;2023-12-15